Inventurus Knowledge Solutions Limited - IPO

1. Comprehensive one-stop platform with diversified offerings across the outpatient and inpatient care value chain serving key stakeholders such as patients, physicians, nurses and healthcare organizations.

2. Leveraging digital evolution, transformation and automation technologies to create sustained value based on outcomes delivered.

3. Strong brand driven by clinical thought leadership through IKS Advisory Board, a healthcare industry leadership forum, and partnerships with industry players and evident through multiple awards and recognitions.

4. Marquee large enterprise clientele that include academic medical centres and healthcare systems, multispecialty and single-specialty medical groups, ancillary healthcare organizations, value enablers, and other outpatient healthcare delivery organizations and client stickiness reflected in revenues from repeat clients of over 98% in the last three Fiscals.

5. Sustainable and scalable business model offering clients flexibility and cost-savings and high-touch engagement through access to project executive sponsors and leadership teams creating cross-selling opportunities.

6. Healthy financial performance with growth and improving margins.

7. Experienced and entrepreneurial driven leadership team.

1. There have been certain FEMA related deficiencies in compliances in the past by our Company and some of our existing and erstwhile shareholders, with respect to issuance of securities of our Company, delays in relation to reporting requirements and transfer of securities of our Company. We have filed compounding applications with the RBI in respect of such contraventions, which are currently pending. Consequently, we may be subject to regulatory actions and penalties/ compounding fees, as applicable.

2. We have outstanding litigation against us, an adverse outcome of which may adversely affect our business, reputation and results of operations.

3. If we fail to successfully develop and introduce new solutions based on artificial intelligence and machine learning technologies and features to existing solutions such as AI-powered speech-to-text solutions, our revenues, operating results and reputation could suffer.

4. The healthcare industry is regulated and if we fail to comply with applicable healthcare laws and government regulations, we could incur financial penalties, be required to make significant operational changes or experience adverse publicity, which could harm our business.

5. Various challenges currently faced by the healthcare industry in the United States including the provision of quality healthcare in a competitive environment and managing costs at the same time and consolidation of healthcare organizations in the United States may adversely affect our business, results of operations and financial condition.

6. Our revenues are dependent on our ability to maintain and expand existing client relationships and our ability to attract new clients. As of September 30, 2024 and 2023 and as of March 31, 2024, 2023 and 2022, we had 778, 42, 853, 49 and 45 clients. A loss of one or more clients could have an adverse impact on our results of operations, financial condition and cash flows.

7. We have recently acquired Aquity Holdings to further our strategic objectives. Our inability to successfully integrate the operations of Aquity or the operations of any entities that we may acquire could adversely impact our business, financial condition, results of operations, cash flows and prospects.

8. Our Company will not receive any proceeds from the Offer. Some of our Shareholders are selling shares in the Offer and will receive proceeds as part of the Offer for Sale.

9. Delays in receiving payment of outstanding dues from clients may affect our financial condition and results of operations.

10. Our revenues are primarily dependent on revenue generated from healthcare organizations based in the United States, and as a result, we are subject to the risks of sector and geographic concentration.